Medications are HSA/FSA eligible, and flat monthly pricing ($149$289/month for semaglutide and tirzepatide) applies to all patients, making it accessible for uninsured and underinsured individuals
At grocery retail, they are spending more on foods that support GLP-1 balance, including vegetables, eggs and nuts
Knowing the difference protects you from serious health risks
Hydration strategies should be intentional
Retatrutide is an unlicensed investigational triple agonist (GLP-1, GIP, glucagon) with no MHRA or EMA marketing authorisation
Many patients ask, what is the tirzepatide maintenance dose after weight loss, and do you need to continue taking it long term